TITLE

The diagnosis and management of acute and chronic leukemia

AUTHOR(S)
Stacy, Tina B.
PUB. DATE
October 2003
SOURCE
Drug Topics;10/6/2003, Vol. 147 Issue 19, p101
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Focuses on the diagnosis and management of acute and chronic leukemia. Epidemiology; Clinical presentation; Diagnosis and staging; Natural history and prognostic factors.
ACCESSION #
11236141

 

Related Articles

  • Molecular events in Chronic Myeloid Leukemia progression. GUERRASIO, Angelo; SERRA, Anna; GOTTARDI, Enrico; CILLONI, Daniela; VISCHIA, Federico; PARVIS, Guido; CILLI, Vania; SAGLIO, Giuseppe // Leukemia (08876924);Apr97 Supplement 3, Vol. 11, p519 

    Chronic myelogenous leukemia presents two distinct clinical phases : the chronic phase is characterised by a marked expansion of the myeloid compartment which still retains a normal differentiative capacity, whereas a differentiation block is the clinical hallmark of the acute transformation....

  • Structure and expression pattern of human ALR, a novel gene with strong homology to ALL-1 involved in acute leukemia and to Drosophila trithorax. Prasad, R; Zhadanov, A B; Sedkov, Y; Bullrich, F; Druck, T; Rallapalli, R; Yano, T; Alder, H; Croce, C M; Huebner, K; Mazo, A; Canaani, E // Oncogene;7/31/97, Vol. 15 Issue 5, p549 

    The ALL-1 gene is involved in human acute leukemia through chromosome translocations or internal rearrangements. ALL-1 is the human homologue of Drosophila trithorax. The latter is a member of the trithorax group (trx-G) genes which together with the Polycomb group (Pc-G) genes act as positive...

  • More Things in Heaven and Earth. Ballard III, J. O. // JAMA: Journal of the American Medical Association;8/19/2009, Vol. 302 Issue 7, p723 

    A personal narrative is presented which explores the experience of the author, who is a doctor, of treating his patient named Emma, who was diagnosed to have acute leukemia, but refused to undergo chemotherapy.

  • Chronic Lymphocytic Leukemia: An Unusual Cause of Upper Gastrointestinal Hemorrhage. Faigel, Douglas O.; Vaughn, David J.; Furth, Emma E.; Metz, David C. // American Journal of Gastroenterology;Apr1995, Vol. 90 Issue 4, p635 

    In contrast to the acute leukemias, chronic lymphocytic leukemia (CLL) is a hematological malignancy with a generally good prognosis. Gastrointestinal (GI) involvement with CLL is unusual, and GI complications generally occur after malignant transformation to diffuse large cell lymphoma...

  • Response to Michele Baccarani. Clarkson, B // Leukemia (08876924);Mar98, Vol. 12 Issue 3, p446 

    Presents the author's response to Michele Baccarani's comment on the article on chronic myelogenous leukemia published (CML) in the 1997 issue of the journal 'Leukemia.' Assumptions regarding the inevitable progression to acute leukemia; Explanation of the behavior of stem cells in CML;...

  • Hepatocellular carcinoma of a short malignant transformation time in a patient with acute myeloblastic leukemia. Mabed, M.; Aref, S.; Aladle, D. A. // Annals of Hematology;May2003, Vol. 82 Issue 5, p318 

    Few cases of hepatocellular carcinoma (HCC) have been described during the course of acute leukemia. The chemotherapy given may be responsible for the development of HCC in such cases. Associated hepatitis may also be responsible. Usually, cancer is a multistep process in which multiple genetic...

  • Patients’ perceptions of having a central venous catheter or a totally implantable subcutaneous port system–results from a randomised study in acute leukaemia. Eva Johansson; Per Engervall; Hjördis Björvell; Robert Hast; Magnus Björkholm // Supportive Care in Cancer;Feb2009, Vol. 17 Issue 2, p137 

    Abstract Goals of work  The selection process of type of central venous access device (CVAD) in patients with acute leukaemia (AL) is generally based on appropriate catheter capacity/function and risk of complications in relation to the planned length of therapy. Advantages and...

  • Complex MLL rearrangements in t(4;11) leukemia patients with absent AF4·MLL fusion allele. Kowarz, E.; Burmeister, T.; Lo Nigro, L.; Jansen, M. W. J. C.; Delabesse, E.; Klingebiel, T.; Dingermann, Theo; Meyer, C.; Marschalek, R. // Leukemia (08876924);Jun2007, Vol. 21 Issue 6, p1232 

    The human mixed lineage leukemia (MLL) gene is frequently involved in genetic rearrangements with more than 55 different translocation partner genes, all associated with acute leukemia. Reciprocal chromosomal translocations generate two MLL fusion alleles, where 5′- and 3′-portions...

  • Relapse After Allogeneic Bone Marrow Transplantation for Acute Leukaemia: A Survey by the EBMT of 117 Cases.  // JAMA: Journal of the American Medical Association;7/14/89, Vol. 262 Issue 2, p218 

    Discusses the abstract of the article 'Relapse after Allogeneic Bone Marrow Transplantation for Acute Leukemia: A Survey by the EBMT of 117 Cases,' by F. Frassoni et al, published in a previous issue of the 'British Journal of Hematology.'

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics